Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QH5K
|
|||
| Former ID |
DIB002865
|
|||
| Drug Name |
AK-106-001616
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
| Company |
Asahi Kasei Pharma Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00902369) A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.